4//SEC Filing
Oesterle Stephen N. 4
Accession 0001415889-22-005830
CIK 0001821323other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:01 PM ET
Size
5.4 KB
Accession
0001415889-22-005830
Insider Transaction Report
Form 4
OESTERLE STEPHEN N
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-26+8,888→ 8,888 totalExercise: $0.76Exp: 2032-05-25→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 26, 2023.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001174532
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:01 PM ET
- Size
- 5.4 KB